Erianin, the main active ingredient of Dendrobium chrysotoxum Lindl, inhibits precancerous lesions of gastric cancer (PLGC) through suppression of the HRAS-PI3K-AKT signaling pathway as revealed by network pharmacology and in vitro experimental verification
Yan Wang, Fuhao Chu, Jie Lin, Yuan Li, Nadia Johnson, Jianglan Zhang, Cong Gai, Zeqi Su, Hong-Jie Cheng, Linheng Wang, Xia Ding
Topics & Concepts
DendrobiumKEGGTraditional medicineIngredientCancerActive ingredientMedicinePharmacologyBiologyGene ontologyGeneInternal medicinePathologyBiochemistryGene expressionBiological and pharmacological studies of plantsPARP inhibition in cancer therapyPhytochemistry and biological activity of medicinal plants